Wellington Management Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Wellington Management Group's STOK Position: Q3 2026 in Review
Wellington Management Group increased its Stoke Therapeutics (STOK) stake by 33% in Q3 2026, buying an estimated $35.1M and bringing the position to 4,681,855 shares worth $122M. The position accounts for 0.02% of the portfolio, ranked #485.
Wellington Management Group first reported a position in STOK in Q2 2019 and has held it in 24 quarters since. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Wellington Management Group held 4,681,855 shares of Stoke Therapeutics worth $122M as of Q3 2026.
- Wellington Management Group bought 1,162,554 Stoke Therapeutics shares in Q3 2026, an estimated $35.1M.
- Stoke Therapeutics made up 0.02% of Wellington Management Group's portfolio in Q3 2026, its #485 holding.
- Wellington Management Group first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 24 quarters since.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.